Join
Live feed
·
SECFilingvia Quantisnow
AN2 Therapeutics Inc. logo

AN2 Therapeutics Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

ByQuantisnow·Wall Street's wire, on your screen.
ANTX· AN2 Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ANTX (AN2 Therapeutics Inc.) and more on Quantisnow.